 EMERYVILLE, Calif.--BUSINESS WIRE--Lucira Health, Inc. Lucira Health or Lucira, a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced the pricing of its upsized initial public offering of 9,000,000 shares of common stock at a price to the public of 17.00 per share. The gross proceeds to Lucira from the offering, before deducting underwriting discounts and commissions and estimated off 